Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer - PubMed (original) (raw)
Comparative Study
. 2007 Dec 14;131(6):1190-203.
doi: 10.1016/j.cell.2007.11.025.
Ailan Guo, Qingfu Zeng, Anthony Possemato, Jian Yu, Herbert Haack, Julie Nardone, Kimberly Lee, Cynthia Reeves, Yu Li, Yerong Hu, Zhiping Tan, Matthew Stokes, Laura Sullivan, Jeffrey Mitchell, Randy Wetzel, Joan Macneill, Jian Min Ren, Jin Yuan, Corey E Bakalarski, Judit Villen, Jon M Kornhauser, Bradley Smith, Daiqiang Li, Xinmin Zhou, Steven P Gygi, Ting-Lei Gu, Roberto D Polakiewicz, John Rush, Michael J Comb
Affiliations
- PMID: 18083107
- DOI: 10.1016/j.cell.2007.11.025
Free article
Comparative Study
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al. Cell. 2007.
Free article
Abstract
Despite the success of tyrosine kinase-based cancer therapeutics, for most solid tumors the tyrosine kinases that drive disease remain unknown, limiting our ability to identify drug targets and predict response. Here we present the first large-scale survey of tyrosine kinase activity in lung cancer. Using a phosphoproteomic approach, we characterize tyrosine kinase signaling across 41 non-small cell lung cancer (NSCLC) cell lines and over 150 NSCLC tumors. Profiles of phosphotyrosine signaling are generated and analyzed to identify known oncogenic kinases such as EGFR and c-Met as well as novel ALK and ROS fusion proteins. Other activated tyrosine kinases such as PDGFRalpha and DDR1 not previously implicated in the genesis of NSCLC are also identified. By focusing on activated cell circuitry, the approach outlined here provides insight into cancer biology not available at the chromosomal and transcriptional levels and can be applied broadly across all human cancers.
Similar articles
- Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Haake SM, Li J, Bai Y, Kinose F, Fang B, Welsh EA, Zent R, Dhillon J, Pow-Sang JM, Chen YA, Koomen JM, Rathmell WK, Fishman M, Haura EB. Haake SM, et al. Clin Cancer Res. 2016 Nov 15;22(22):5605-5616. doi: 10.1158/1078-0432.CCR-15-1673. Epub 2016 May 24. Clin Cancer Res. 2016. PMID: 27220961 Free PMC article. - The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.
Jun HJ, Johnson H, Bronson RT, de Feraudy S, White F, Charest A. Jun HJ, et al. Cancer Res. 2012 Aug 1;72(15):3764-74. doi: 10.1158/0008-5472.CAN-11-3990. Epub 2012 Jun 1. Cancer Res. 2012. PMID: 22659450 Free PMC article. - Anaplastic lymphoma kinase as a therapeutic target in anaplastic large cell lymphoma, non-small cell lung cancer and neuroblastoma.
Cheng M, Ott GR. Cheng M, et al. Anticancer Agents Med Chem. 2010 Mar;10(3):236-49. doi: 10.2174/1871520611009030236. Anticancer Agents Med Chem. 2010. PMID: 20406193 Review. - ALK inhibitors in the treatment of advanced NSCLC.
Gridelli C, Peters S, Sgambato A, Casaluce F, Adjei AA, Ciardiello F. Gridelli C, et al. Cancer Treat Rev. 2014 Mar;40(2):300-6. doi: 10.1016/j.ctrv.2013.07.002. Epub 2013 Aug 7. Cancer Treat Rev. 2014. PMID: 23931927 Review.
Cited by
- EML4-ALK positive lung adenocarcinoma with skeletal muscle metastasis in the right calf which was treatable with lorlatinib after resistance to treatment with alectinib.
Matsuda H, Hara M, Iwakami SI, Takahashi K. Matsuda H, et al. BMJ Case Rep. 2021 Apr 27;14(4):e240295. doi: 10.1136/bcr-2020-240295. BMJ Case Rep. 2021. PMID: 33906872 Free PMC article. - Computational methods and opportunities for phosphorylation network medicine.
Chen YA, Eschrich SA. Chen YA, et al. Transl Cancer Res. 2014 Jun 1;3(3):266-278. Transl Cancer Res. 2014. PMID: 25530950 Free PMC article. - Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK.
Rothschild SI. Rothschild SI. Cancers (Basel). 2015 May 26;7(2):930-49. doi: 10.3390/cancers7020816. Cancers (Basel). 2015. PMID: 26018876 Free PMC article. Review. - Phosphorylation and assembly of glutamate receptors after brain ischemia.
Zhang F, Guo A, Liu C, Comb M, Hu B. Zhang F, et al. Stroke. 2013 Jan;44(1):170-6. doi: 10.1161/STROKEAHA.112.667253. Epub 2012 Dec 4. Stroke. 2013. PMID: 23212166 Free PMC article. - Loss of Fer Jeopardizes Metabolic Plasticity and Mitochondrial Homeostasis in Lung and Breast Carcinoma Cells.
Mehazri L, Shpungin S, Bel S, Nir U. Mehazri L, et al. Int J Mol Sci. 2021 Mar 25;22(7):3387. doi: 10.3390/ijms22073387. Int J Mol Sci. 2021. PMID: 33806191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous